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Supplementary Materials and Methods 
S1. qPCR 
For the detection of lncRNAs’ expression in the glomeruli and the whole mouse kidneys, we performed 
quantitative RT-PCR analyses. Glomeruli isolation was carried out with magnetic beads as described 
previously [40]. Total RNA was extracted from whole kidney samples and isolated glomeruli using the 
Direct-zol RNA Kit (Zymo Research). The quantity of extracted RNA was measured using a Qubit 4 
Fluorometer (Invitrogen). The cDNA was synthesized from 2 μg of total RNA using the High-Capacity cDNA 
Reverse Transcription Kit (Applied Biosystem). The qPCR was performed for following targets: Wt1os, 
4921504A21Rik, Gm10824, Gm28876 and Gm26759, using the custom TaqMan PrimeTime assays 
(Integrative DNA Technologies) and TaqMan™ Gene Expression qPCR Assay MasterMix (Applied 
Biosystems), according to the manufacturer’s recommendations. The analyses were run with 7900HT Fast 
Real-Time PCR System (Applied Biosystem), using Sequence Detection Systems Software version 2.4 
software (Applied Biosystem). The TaqMan PrimeTime primer and probe sequences are listed in the Table 
S1. All qPCR reactions were performed under the following conditions: 1 cycle at 95 °C for 10 min; 40 
cycles of 95 °C for 15 s, 60 °C for 60 s, and 1 cycle at 72 °C for 10 min. The TaqMan PrimeTime assays 
spanned an intron to avoid unwanted amplification of genomic DNA. Analysis was performed using the 
2−∆∆Ct method, with mouse POLR2A as a reference gene. To control for possible contamination, water 
blanks were placed in the PCR run. An unpaired t-test was used to test statistical significance with P value 
< 0.05 considered to indicate a statistically significant difference (*P < 0.05; **P < 0.01; ***P < 0.001). The 
graphs were drawn using GraphPad 6 software.  
 
Primers and probes sequences 
Gene Forward primer Reverse primer Probe 





















Detailed information of the RNAscope probes 
 
Gene Probe name Cat no. Targeted region 
Wt1os Mm-Wt1os 577401 264-1227 of ENSMUST00000172701.7 
4921504A21Rik Mm-4921504A21Rik 851511 52-1522 of ENSMUSG00000097626.5 
Gm10824 Mm-Gm10824 851521 2-915 of ENSMUST00000220000.1 
XLOC_024349 Mm-Novel24 








For the glomerular RNAseq datasets, libraries were prepared with the Illumina TruSeq stranded ribo 
zero gold protocol. The first step involves the removal of ribosomal RNA using biotinylated target-
specific oligos combined with Ribo-Zero rRNA removal beads from 1ug totalRNA input. The Ribo-Zero 
Human/Mouse/Rat gold kit depletes samples of cytoplasmic and mitochondrial rRNA. Following 
purification, the RNA is fragmented into small pieces using divalent cations under elevated temperature. 
The cleaved RNA fragments are copied into first strand cDNA using reverse transcriptase and random 
primers, followed by second strand cDNA synthesis using DNA Polymerase I and RNase H. These cDNA 
fragments then have the addition of a single'A' base and subsequent ligation of the adapter. The 
products are purified and enriched with PCR (20ul template, 15cycles) to create the final cDNA library. 
After library validation and quantification (Agilent 4200 tape station), equimolar amounts of library were 
pooled. Pools were quantified by using the Peqlab KAPA Library Quantification Kit and the Applied 
Biosystems 7900HT Sequence Detection System and sequenced on an Illumina NovaSeq6000 sequencer 




The RNAscope probes’ catalog numbers and targeted regions are listed in the Table S2. All the procedures 
were performed according to manufacturer’s guidelines for the FFPE tissue. In brief, FFPE sections were 
deparaffinized, followed by 10 minutes of hydrogen peroxide pretreatment, incubation in Target Retrieval 
Reagent for 30 minutes, and permeabilization with protease for 30 minutes at 40 °C. Tissue sections were 
then incubated with ACD mouse target probes for 2 h at 40 °C. The slides were washed thoroughly using 
the wash buffer (ACD, Inc.) after each step at room temperature. Amplification steps were performed and 
diaminobenzidine (DAB) was used as the chromogen. The samples were counterstained using 
Hematoxylin Solution, Gill No. 1 (Sigma-Aldrich). Positive (mouse Ppib) and negative (DapB) control 
probes were included in each experiment. The positive staining was identified based on brown punctate 
spotting in the nucleus and/or cytoplasm. Representative images were captured using the Slide Scanner 











Supplementary figure legends 
Supplementary figure 1. Graphical representation of urine albumin-to-creatinine ratios (UCAR) in 
BALB/c mice 5 days after intravenous injection of adriamycin in comparison to untreated control mice. 
Supplementary figure 2. Graphical representation of qPCR data shown in figure 4A. The expression of 
the shown transcripts was compared between RNA extracted from mouse glomeruli and whole kidneys. 
The results are representative of three biological replicates, using three technical replicates for whole 
kidney and two for glomerular RNA. The fold change (glomeruli over whole kidney) was calculated using 
the delta-delta Ct method with Polr2a as a control gene. An unpaired t-test was used to detect 
significant differences between expression in glomeruli and whole kidney. ***p<0.001, **p<0.01, 
*p<0.05 
Supplementary figure 3. Localization of Wt1os (A), 4921504A21Rik (B), Gm10824 (C) and XLOC_024349 
(D) by RNAscope. Representative images of glomeruli and tubules analyzed with custom designed 
RNAscope probes for lncRNAs Wt1os, 4921504A21Rik, Gm10824 and XLOC_024349 shown in figure 
4A/B. Target lncRNAs were detected with the RNAscope 2.5 HD – brown assay on FFPE mouse kidney 
tissue sections. Probe binding is visualized as punctate brown dots. Counterstain: hematoxylin (blue). 
Scale bar: 60 µm. 
Supplementary figure 4. Localization of WT1-AS, the human homolog of Wt1os, shown in figure 4C. A) 
WT1-AS and controls were detected with the RNAscope 2.5 HD – brown assay on FFPE human kidney 
tissue sections. Probe binding is visualized as punctate brown dots. Counterstain: hematoxylin (blue). 
Scale bar: 200µm. B) Additional image of human glomeruli and tubules analyzed with the custom 
designed RNAscope probe for WT1-AS.  
Supplementary Table legends  
Supplementary Table 1. Excel spreadsheet containing the output of all analyses of the RNAseq data 
performed. Descriptions of the individual columns are provided below. calinca.dieterichlab.org provides 
an interactive version of this table allowing for both user-defined content and visualization of the data. 
Column descriptions 
XLOCid - unique gene ID generated by Cufflinks 
GeneSymbol - unique abbreviation for Ensembl annotated mouse lncRNA gene or XLOC ID for the novel 
genes 
GenomicCoordinates - Ensembl based genomic locus coordinates 
ExonNumber - Number of exons per transcript 
TranscriptLength - Length of the transcripts in bases 
Podocytes.FPKM - FPKM of lncRNA genes from FACS sorted podocytes (wildtype) 
Glomerulus.FPKM - FPKM of lncRNA genes from isolated glomeruli (wildtype) 
WholeKidney.FPKM - FPKM of lncRNA genes from whole mouse kidneys (wildtype) 
TauMeasure - Tissue specificity index calculated as described by Kryuchkova-Mostacci et al., 2017 (DOI: 
10.1093/bib/bbw008). LncRNAs with an index of > 0.8 are considered tissue-specific. 
TauClassification - Tissue specificity classification based on TauMeasure (cutoff 0.8), indicates in which 
tissue the lncRNA is enriched. 
Podocyte.Enriched.Transcript – Transcript enriched in podocytes over glomeruli and whole kidney based 
on Tau analysis 
Podocyte.Expressed.Transcript –Transcript showing FPKM > 0 in podocytes 
SequenceConservation - sequence homology-based gene conservation analysis, indicates whether the 
lncRNA is conserved between mouse and human based on sequence homology (BLASTN) 
SyntenyConservation - synteny-based gene conservation analysis, indicates whether the gene order of 
the lncRNA gene surrounding protein coding genes is conserved between mouse and human 
(CYNTENATOR, Rödelspeger & Dieterich, 2010) 
Human.Expressed.GTEX – lncRNA, the homolog of which is found expressed in human kidney cortex 
(based on an analysis of datasets from the GTEx database) 
Wt1.2factor.log2FC - Log2 fold change of gene expression for 4 and 12 week samples of the Wt1+/- disease 
model analyzed in a combined fashion using a two-factor model 
Wt1.2factor.FDR - Combined False Discovery Rate value for 4 and 12 week samples of the Wt1+/- disease 
model analyzed in a combined fashion using a two-factor model 
Wt1.4.FDR - False Discovery Rate values for the 4 week samples of the Wt1+/- disease model 
Wt1.4.log2FC - Log2 fold change of gene expression for the 4 week samples of the Wt1+/- disease model 
Wt1.12.FDR - False Discovery Rate values for the 12 week samples of the Wt1+/- disease model 
Wt1.12.log2FC - Log2 fold change of gene expression for the 12 week samples of the Wt1+/- disease model 
Pod.R231Q_A286V.12.FDR - False Discovery Rate values for the 12 week samples of the PodocinR231Q_A286V 
disease model 
Pod.R231Q_A286V.12.log2FC – Log2 fold change of gene expression for the 12 week samples of the 
PodocinR231Q_A286V disease model 
Pod.R231Q_A286V.2Factor.FDR – Combined False Discovery Rate value for 4 and 12 week samples of the 
PodocinR231Q_A286V disease model analyzed in a combined fashion using a two-factor model 
Pod.R231Q_A286V.2Factor.log2FC – Log2 fold change of gene expression for 4 and 12 week samples of 
the PodocinR231Q_A286V disease model analyzed in a combined fashion using a two-factor model 
Pod.R231Q_A286V.4.FDR – False Discovery Rate values for the 4 week samples of the PodocinR231Q_A286V 
disease model 
Pod.R231Q_A286V.4.log2FC – Log2 fold change of gene expression for the 4 week samples of the 
PodocinR231Q_A286V disease model 
Adriamycin.FDR - False Discovery Rate values for the adriamycin disease model 
Adriamycin.log2FC - Log2 fold change of gene expression for the adriamycin disease model 
DE.Adriamycin – Classification (yes/no) of differentially expressed genes in the adriamycin dataset (FDR 
< 0.05 in at least one of the three analyses) 
DE.Podocin - Classification (yes/no) of differentially expressed genes in the PodocinR231Q_A286V dataset (FDR 
< 0.05 in at least one of the three analyses) 
DE.WT1 – Classification (yes/no) of differentially expressed genes in the Wt1+/- dataset (FDR < 0.05 in at 
least one of the three analyses) 
Podocyte.Enriched.Boerries.FDR - False Discovery Rate values for lncRNA enrichment in podocytes, 
calculated using data from sorted glomerular cells (Boerries et al., Kidney Int. 2013) 
Podocyte.Enrichment.Boerries.log2FC - Log2 fold change of lncRNA enrichment in podocytes, calculated 
using data from sorted glomerular cells (Boerries et al., Kidney Int. 2013) 
Podocyte.Enriched.Boerries – Classification (yes/no) of lncRNAs enriched in podocytes based on the 
datasets from Boerries et al., Kidney Int. 2013 
Novel – Indicates whether the lncRNA is novel or known (annotated) 
Chung.control1.pValue – p value of wilcox.test (GSM4409507) for podocyte enrichment in scRNA 
sequencing by Chung et al., 2020 
Chung.control2.pValue – p value of wilcox.test (GSM4409508) for podocyte enrichment in scRNA 
sequencing by Chung et al., 2020 
Chung.control3.pValue – p value of wilcox.test (GSM4409509) for podocyte enrichment in scRNA 
sequencing by Chung et al., 2020 
scRNAseq.Chung.confirmed – lncRNA expression confirmed (yes/no) by scRNA sequencing (Chung et al., 
2020) 
NcRNA.GeneID.HSA – Ensembl gene ID of conserved, annotated human lncRNA gene 
GeneID.EnsemblHSA.ProteinCoding – Gene identifier of known human protein coding anchor gene 
annotated in Ensembl database in our synteny assessment 
GeneID.EnsemblMMU.ProteinCoding – Gene identifier of known mouse protein coding anchor gene 
annotated in Ensembl database in our synteny assessment 
GeneSymbol.HSA - unique abbreviation for Ensembl annotated human lncRNA gene 
Distance.MMU – Distance in base pairs between lncRNA and the closest protein-coding gene 
Distance.HSA – Distance in base pairs between human homolog lncRNA and the closest protein-coding 
gene 
ClosestNcTx – A human noncoding gene closest to the human protein homolog in our synteny assessment. 
NcRNASymbol – Gene symbol of conserved, annotated human lncRNA gene 
ConservedHumanTX - Ensembl transcript identifier of human conserved lncRNA as identified by 
SequenceConservation 
Transcript.ID - unique transcript ID generated by Cufflinks 
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Supplementary figure 4
